Good morning, everyone, and thank you so much for joining us. I want to start by briefly framing where Recursion is today and its journey and evolution. Over the past decade, Recursion has built ...

In case you had any doubt, Elon Musk’s X has an algorithm that favors conservative content posted by political activists over liberal content or posts by traditional news media accounts, according to ...

When X's engineering team published the code that powers the platform's "for you" algorithm last month, Elon Musk said the move was a victory for transparency. "We know the algorithm is dumb and needs ...

In 2023, the website then known as Twitter partially open sourced its algorithm for the first time. In those days, Tesla billionaire Elon Musk had only recently acquired the platform, and he claimed ...

X is revamping the algorithm that ranks posts in the "For You" feed. The engineering team said it will post changes to the algorithm on GitHub every four weeks, including explainers on changes. The ...

He open-sourced Twitter’s algorithm back in 2023, but then never updated the GitHub. He open-sourced Twitter’s algorithm back in 2023, but then never updated the GitHub. is the Verge’s weekend editor.

Would you watch a movie generated entirely by AI? Or read a novel written by an algorithm? Examples of AI-generated art are pretty astounding, and users are now able to create hyper-realistic videos ...

We may receive a commission on purchases made from links. For the first time, Instagram will start letting you control the topics its algorithm recommends, much as you now can on TikTok. The new ...

The clinical-stage biotech might have a successful drug on its hands, if a relatively early-stage clinical trial is any indication. Its REC-4881 did very well in the testing. 10 stocks we like better ...

Threads is testing a new way for users to manipulate their own recommendation algorithm. The feature, aptly called "Dear algo," allows users to post a message to the algorithm with the note "dear algo ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...